ArticleClinical and translational radiation oncology2026
Outcomes of pelvic radiotherapy with boost strategies in high nodal-risk prostate cancer: A phase 2 prospective trial.
Camilla Thellenberg Karlsson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.